Searched for
INDIAN PHARMACEUTICAL MARKET GROWTH
Nifty to rally 50% in 3 years? Prashant Jain thinks so and he's buying small and midcapsVeteran investor Prashant Jain expects the Nifty to deliver 45–50% returns over three years, supported by earnings growth and valuation re-...- India Inc's revenue growth to hit 2-year high of 11-11.5% in Q1 despite Iran war: CrisilIndia Inc's revenue is estimated to have grown 11-11.5% year-on-year in Q1FY27, marking the fastest pace in eight quarters, according to Cr...
- Pharma companies' Q1 margins likely to decline despite revenue growth: Goldman SachsIndian pharmaceutical firms anticipate revenue increases in the first quarter of fiscal year twenty twenty six twenty seven. Profitability ...
- EQT To List Data Analytics firm Straive in $400 million IPOSwedish firm EQT Partners plans a $400 million IPO for its platform Straive. The India-focused company is expected to be valued at $2.5 bil...
- Torrent Pharma among 6 stocks to hit 52-week highs & rally up to 25% in a monthDespite a sharp sell-off in the broader market, six BSE 200 stocks touched fresh 52-week highs, highlighting resilient investor confidence....
- Marksans Pharma to acquire Germany-based ABCnow GmbHMarksans Pharma announced its definitive agreement to acquire ABCnow GmbH. This German pharmaceutical distributor will be purchased for nea...
- Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark PharmaMarkets traded subdued on the weekly expiry day, with indices ending marginally lower. Cochin Shipyard's offer for sale saw strong investor...
- Trent slides 12% as Q1 growth fails to impressTrent shares experienced a significant single-day decline on Tuesday. This drop followed first-quarter financial results that did not meet ...
- India-UK FTA takes effect on July 15, but the real test lies beyond tariff cutsIndia-UK FTA success depends on improving competitiveness of Indian manufacturers, say industry experts.
- Regulator seeks views to curb similar sounding drug brandsThe Central Drugs Standard Control Organisation in India is inviting public contributions concerning new regulations aimed at curbing the s...
- Glenmark launches generic Olanzapine injection in USGlenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment for schizophreni...
- Radico Khaitan eyes 20 pc volume growth in premium portfolio in FY27Radico Khaitan anticipates a robust 20% growth in its premium spirits segment this fiscal year, alongside a 120 basis point margin expansio...
- Indian toy market holds strong growth potential: China Toy Association ChairA delegation from China, Taiwan and Hong Kong visited the Indian toy show, where industry representatives explored opportunities for collab...
- Indian envoy pitches greater pharma exports, Chinese investment to deepen tiesIndia's ambassador to China, Vikram Doraiswami, stressed the importance of expanding access to Chinese markets for Indian pharmaceutical co...
- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Telangana bets big on drug discovery hubTelangana is gearing up to elevate Hyderabad's pharmaceutical standing beyond manufacturing. The state is fostering an integrated ecosystem...
- India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
Load More
